These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 33754031)

  • 1. The double-edged roles of ROS in cancer prevention and therapy.
    Wang Y; Qi H; Liu Y; Duan C; Liu X; Xia T; Chen D; Piao HL; Liu HX
    Theranostics; 2021; 11(10):4839-4857. PubMed ID: 33754031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox biology of regulated cell death in cancer: A focus on necroptosis and ferroptosis.
    Florean C; Song S; Dicato M; Diederich M
    Free Radic Biol Med; 2019 Apr; 134():177-189. PubMed ID: 30639617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies.
    Kalyanaraman B; Cheng G; Hardy M; Ouari O; Bennett B; Zielonka J
    Redox Biol; 2018 May; 15():347-362. PubMed ID: 29306792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenesis and Reactive Oxygen Species Signaling: Interaction of the NADPH Oxidase NOX1-5 and Superoxide Dismutase 1-3 Signal Transduction Pathways.
    Parascandolo A; Laukkanen MO
    Antioxid Redox Signal; 2019 Jan; 30(3):443-486. PubMed ID: 29478325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ROS-induced ROS release in vascular biology: redox-redox signaling.
    Zinkevich NS; Gutterman DD
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H647-53. PubMed ID: 21685266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors.
    Zhu J; Xiong Y; Zhang Y; Wen J; Cai N; Cheng K; Liang H; Zhang W
    Oxid Med Cell Longev; 2020; 2020():8810785. PubMed ID: 33425217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Double-Edged Sword Profile of Redox Signaling: Oxidative Events As Molecular Switches in the Balance between Cell Physiology and Cancer.
    Emanuele S; D'Anneo A; Calvaruso G; Cernigliaro C; Giuliano M; Lauricella M
    Chem Res Toxicol; 2018 Apr; 31(4):201-210. PubMed ID: 29513521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive oxygen species in redox cancer therapy.
    Tong L; Chuang CC; Wu S; Zuo L
    Cancer Lett; 2015 Oct; 367(1):18-25. PubMed ID: 26187782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selenium compounds in redox regulation of inflammation and apoptosis].
    Rusetskaya NY; Fedotov IV; Koftina VA; Borodulin VB
    Biomed Khim; 2019 Apr; 65(3):165-179. PubMed ID: 31258141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy.
    Marengo B; Nitti M; Furfaro AL; Colla R; Ciucis CD; Marinari UM; Pronzato MA; Traverso N; Domenicotti C
    Oxid Med Cell Longev; 2016; 2016():6235641. PubMed ID: 27418953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
    Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
    Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species.
    He L; He T; Farrar S; Ji L; Liu T; Ma X
    Cell Physiol Biochem; 2017; 44(2):532-553. PubMed ID: 29145191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer.
    Zhang L; Li J; Zong L; Chen X; Chen K; Jiang Z; Nan L; Li X; Li W; Shan T; Ma Q; Ma Z
    Oxid Med Cell Longev; 2016; 2016():1616781. PubMed ID: 26881012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Double-edged sword" effect of reactive oxygen species (ROS) in tumor development and carcinogenesis.
    Zhao W; Zhuang P; Chen Y; Wu Y; Zhong M; Lun Y
    Physiol Res; 2023 Jul; 72(3):301-307. PubMed ID: 37449744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative cell death in cancer: mechanisms and therapeutic opportunities.
    An X; Yu W; Liu J; Tang D; Yang L; Chen X
    Cell Death Dis; 2024 Aug; 15(8):556. PubMed ID: 39090114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.
    Gao L; Mann GE
    Cardiovasc Res; 2009 Apr; 82(1):9-20. PubMed ID: 19179352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive Oxygen and Nitrogen Species-Induced Protein Modifications: Implication in Carcinogenesis and Anticancer Therapy.
    Moldogazieva NT; Lutsenko SV; Terentiev AA
    Cancer Res; 2018 Nov; 78(21):6040-6047. PubMed ID: 30327380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.
    Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N
    Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidants as therapeutics in the intensive care unit: Have we ticked the redox boxes?
    Margaritelis NV
    Pharmacol Res; 2016 Sep; 111():126-132. PubMed ID: 27270047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Physiological Redox Signalling to Oxidant Stress.
    Ward JPT
    Adv Exp Med Biol; 2017; 967():335-342. PubMed ID: 29047097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.